December 7, 2021
FDA approves Cortrophin Gel for rheumatoid arthritis, multiple sclerosis
- /
November 2021 The FDA has approved a supplemental new drug application for ANI Pharmaceutical’s Cortrophin Gel to treat rheumatoid arthritis,…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
December 7, 2021
Relapse comparable among common DMTs for MS
- /
- /
Dimethyl fumarate and fingolimod appeared to have no significant difference in relapse rates, and rituximab appeared to have better relapse…
December 7, 2021
Timing of rituximab infusion not tied to risk for COVID-19 hospitalization
- /
- /
December 6, 2021 The timing of rituximab infusion or cumulative lifetime rituximab dose did not appear statistically significantly associated with…
December 6, 2021
What are the different kinds of Multiple sclerosis pain?
- /
Special to Gulf News Understanding and being able to communicate the different types of pain is key If you’re reading…
December 6, 2021
What Causes MS?
- /
Overview The cause of MS is not known. Scientists believe MS is triggered by a combination of factors. To…
December 6, 2021
Video: Lean into Life’s Turns, while living with Multiple Sclerosis
- /
Listen to MS Patient Paul Pelland’s motivational story, involving his motorcycle and MS Visit our MS Learning Channel on…
December 6, 2021
Managing MS – A Roadmap to Navigate Multiple Sclerosis, by Debbie Petrina
- /
It’s done! The second edition of my book Managing MS is out, and I would love for you to read…
November 30, 2021
Results of International Mesenchymal Stem Cell Trial Suggest No Benefits Against Inflammation in Active MS
- /
- /
November 4, 2021 Results have been published from a phase 2 clinical trial conducted at 15 sites in 9 countries,…
November 30, 2021
Teriflunomide Study in Kids with MS Does Not Meet Primary Endpoint, But Reduces MRI Activity
- /
November 29, 2021 —Do We Need Different Ways to Measure Treatment Effectiveness in Children with MS?In a recently published study…
November 29, 2021
Siponimod’s Efficacy on Secondary Progressive MS in Older age groups
- /
- /
October 28, 2021 – Le Hua, MD ranscript below. Le Hua, MD: The original EXPAND study had been presented, so…
